Novolin N 00169-1834
Generic: Human Insulin
Product NDC
00169-1834- Manufacturer
- Novo Nordisk
- Dosage Form
- Injection, Suspension
- Route
- Subcutaneous
- Product Type
- Human Otc Drug
- Marketing Start
- July 1, 1991
- Listing Expires
- December 31, 2026
- Application
- BLA019959
Active Ingredients
| Ingredient | Strength |
|---|---|
| Insulin Human | 100 [iU]/mL |
Drug Class
Insulin [EPC]Insulin [CS]Insulin [EPC]
Packaging Options(2)
1 VIAL in 1 CARTON (0169-1834-02) / 10 mL in 1 VIAL
1 VIAL in 1 CARTON (0169-1834-11) / 10 mL in 1 VIAL